Nippon Chemiphar Co., Ltd. (4539.T)
JPY 1512.0
(-0.13%)
JPY 1512.0
(-0.13%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 8.23 Billion JPY | -2.29% |
| 2022 | 8.42 Billion JPY | 2.15% |
| 2021 | 8.24 Billion JPY | -24.18% |
| 2020 | 10.87 Billion JPY | -10.75% |
| 2019 | 12.19 Billion JPY | -6.68% |
| 2018 | 13.06 Billion JPY | -6.34% |
| 2017 | 13.94 Billion JPY | 4.06% |
| 2016 | 13.4 Billion JPY | -1.83% |
| 2015 | 13.65 Billion JPY | 1.28% |
| 2014 | 13.48 Billion JPY | 0.32% |
| 2013 | 13.43 Billion JPY | 2.21% |
| 2012 | 13.14 Billion JPY | 3.37% |
| 2011 | 12.71 Billion JPY | 2.8% |
| 2010 | 12.37 Billion JPY | 5.13% |
| 2009 | 11.76 Billion JPY | 3.77% |
| 2008 | 11.33 Billion JPY | 3.39% |
| 2007 | 10.96 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 1.94 Billion JPY | -6.84% |
| 2024 Q1 | 2.09 Billion JPY | -11.06% |
| 2023 FY | 8.23 Billion JPY | -2.29% |
| 2023 Q3 | 1.95 Billion JPY | -1.22% |
| 2023 Q2 | 1.97 Billion JPY | 0.87% |
| 2023 Q1 | 1.95 Billion JPY | -13.75% |
| 2023 Q4 | 2.35 Billion JPY | 20.56% |
| 2022 FY | 8.42 Billion JPY | 2.15% |
| 2022 Q1 | 2.05 Billion JPY | -9.41% |
| 2022 Q4 | 2.26 Billion JPY | 9.99% |
| 2022 Q2 | 2.04 Billion JPY | -0.34% |
| 2022 Q3 | 2.06 Billion JPY | 0.98% |
| 2021 Q4 | 2.26 Billion JPY | 20.24% |
| 2021 Q1 | 2.07 Billion JPY | -19.82% |
| 2021 Q2 | 2.03 Billion JPY | -1.88% |
| 2021 Q3 | 1.88 Billion JPY | -7.38% |
| 2021 FY | 8.24 Billion JPY | -24.18% |
| 2020 Q3 | 2.72 Billion JPY | -8.87% |
| 2020 Q4 | 2.58 Billion JPY | -5.07% |
| 2020 FY | 10.87 Billion JPY | -10.75% |
| 2020 Q1 | 2.58 Billion JPY | -12.77% |
| 2020 Q2 | 2.98 Billion JPY | 15.33% |
| 2019 Q1 | 3.03 Billion JPY | -7.46% |
| 2019 FY | 12.19 Billion JPY | -6.68% |
| 2019 Q2 | 3.21 Billion JPY | 5.89% |
| 2019 Q3 | 2.96 Billion JPY | -7.86% |
| 2019 Q4 | 2.96 Billion JPY | 0.1% |
| 2018 Q2 | 3.27 Billion JPY | 2.09% |
| 2018 Q1 | 3.2 Billion JPY | -6.45% |
| 2018 Q4 | 3.28 Billion JPY | -0.36% |
| 2018 FY | 13.06 Billion JPY | -6.34% |
| 2018 Q3 | 3.29 Billion JPY | 0.64% |
| 2017 Q2 | 3.56 Billion JPY | 4.58% |
| 2017 Q1 | 3.4 Billion JPY | 0.0% |
| 2017 FY | 13.94 Billion JPY | 4.06% |
| 2017 Q4 | 3.42 Billion JPY | -3.35% |
| 2017 Q3 | 3.54 Billion JPY | -0.42% |
| 2016 Q2 | 3.38 Billion JPY | 4.9% |
| 2016 Q4 | 3.4 Billion JPY | 0.5% |
| 2016 FY | 13.4 Billion JPY | -1.83% |
| 2016 Q3 | 3.39 Billion JPY | 0.24% |
| 2016 Q1 | 3.22 Billion JPY | -4.62% |
| 2015 Q4 | 3.38 Billion JPY | -3.26% |
| 2015 FY | 13.65 Billion JPY | 1.28% |
| 2015 Q3 | 3.49 Billion JPY | 3.56% |
| 2015 Q2 | 3.37 Billion JPY | -0.91% |
| 2015 Q1 | 3.4 Billion JPY | 3.12% |
| 2014 Q3 | 3.54 Billion JPY | 7.17% |
| 2014 Q4 | 3.3 Billion JPY | -6.8% |
| 2014 FY | 13.48 Billion JPY | 0.32% |
| 2014 Q1 | 3.32 Billion JPY | 0.06% |
| 2014 Q2 | 3.3 Billion JPY | -0.69% |
| 2013 Q3 | 3.56 Billion JPY | 9.99% |
| 2013 Q4 | 3.32 Billion JPY | -6.75% |
| 2013 FY | 13.43 Billion JPY | 2.21% |
| 2013 Q1 | 3.29 Billion JPY | 1.32% |
| 2013 Q2 | 3.24 Billion JPY | -1.64% |
| 2012 Q3 | 3.44 Billion JPY | 7.65% |
| 2012 Q1 | 3.24 Billion JPY | 5.09% |
| 2012 Q4 | 3.25 Billion JPY | -5.6% |
| 2012 FY | 13.14 Billion JPY | 3.37% |
| 2012 Q2 | 3.2 Billion JPY | -1.17% |
| 2011 Q2 | 3.19 Billion JPY | 3.43% |
| 2011 Q3 | 3.34 Billion JPY | 4.57% |
| 2011 Q4 | 3.08 Billion JPY | -7.78% |
| 2011 FY | 12.71 Billion JPY | 2.8% |
| 2011 Q1 | 3.09 Billion JPY | 0.78% |
| 2010 FY | 12.37 Billion JPY | 5.13% |
| 2010 Q3 | 3.27 Billion JPY | 10.04% |
| 2010 Q1 | 3.05 Billion JPY | -1.23% |
| 2010 Q4 | 3.06 Billion JPY | -6.35% |
| 2010 Q2 | 2.97 Billion JPY | -2.39% |
| 2009 Q2 | 2.83 Billion JPY | -1.59% |
| 2009 Q1 | 2.88 Billion JPY | 6.89% |
| 2009 FY | 11.76 Billion JPY | 3.77% |
| 2009 Q4 | 3.08 Billion JPY | 4.5% |
| 2009 Q3 | 2.95 Billion JPY | 4.09% |
| 2008 Q2 | 2.95 Billion JPY | 0.0% |
| 2008 Q4 | 2.69 Billion JPY | -4.29% |
| 2008 FY | 11.33 Billion JPY | 3.39% |
| 2008 Q3 | 2.82 Billion JPY | -4.57% |
| 2007 FY | 10.96 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 81.136% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 99.686% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 98.482% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 95.835% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -120.321% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 87.457% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | 71.639% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 98.456% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -55.85% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 87.49% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 82.208% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | 28.746% |
| Tsumura & Co. | 48.8 Billion JPY | 83.131% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | 75.297% |
| Torii Pharmaceutical Co., Ltd. | 19.53 Billion JPY | 57.865% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 87.084% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | 34.961% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 79.656% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 81.866% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -98.027% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -38.469% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -57.62% |
| MedRx Co., Ltd | 959 Million JPY | -758.394% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -186.457% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -457.724% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -247.244% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | 65.934% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 76.767% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -1019.724% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 91.753% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -264.686% |